Startseite>>Signaling Pathways>> PROTAC>>DB1113

DB1113

Katalog-Nr.GC68942

DB1113 (Beispiel 24) ist eine bifunktionale Verbindung, die auf die gezielte Degradation von Protein-Kinasen abzielt. DB1113 kann ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20 , MAP4K1 , MAP4K2 , MAP4K3 , MAP4K5 , MAPK14 , MAPK7 , MAP K8 ,MAP K9,M APKAP K2,M APKAP K3,NLK,PDIKL1L,PTKB,RIPKI,RPS6KA1,RPS6KA3,SIk2、SIk3、STk35、TNk2和ULK1 abbauen. DB1113 kann zur Untersuchung von Krankheiten oder Störungen verwendet werden,die durch abnorme Kinaseaktivität vermittelt werden.

Products are for research use only. Not for human use. We do not sell to patients.

DB1113 Chemische Struktur

Cas No.: 2769753-53-7

Größe Preis Lagerbestand Menge
5mg
765,00 $
Auf Lager
10mg
1.305,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of DB1113

Cas No. 2769753-53-7 SDF
Formula C59H68F3N13O6S M.Wt 1144.31
Löslichkeit DMSO : 60 mg/mL (52.43 mM; Need ultrasonic) Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of DB1113

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 0.8739 mL 4.3694 mL 8.7389 mL
5 mM 0.1748 mL 0.8739 mL 1.7478 mL
10 mM 0.0874 mL 0.4369 mL 0.8739 mL
  • Molaritätsrechner

  • Verdünnung-Rechner

  • Molecular Weight Calculator

Gewicht
=
Konzentration
x
Inhalt
x
MW*
 
 
 
**Bei der Herstellung von Stammlösungen ist immer das chargenspezifische Molekulargewicht von

Berechnen

In vivo Formulation Calculator (Clear solution) of DB1113

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Bewertungen

Review for DB1113

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DB1113

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.